Bevacizumab (Avastin®) aerosol therapy (AT) inhibits primary and metastatic tumor growth in a murine model with human non-small cell lung cancer (NSCLC)
Yehuda Schwarz, Alex Starr, Alexandra Litinsky, Lilah Israeli, Ofer Merimsky
European Respiratory Journal 2012 40: 3262; DOI: